1-(800)-800-3332

FDA Approves New Drug for Patients with Atrial Fibrillation

Posted on February 15, 2016 by Disability Help Group

Atrial fibrillation is a disorder that can increase the risk of an individual suffering a stroke. If you have been diagnosed with a heart condition or any severe medical condition that requires you to take an extended period of time off from work, you may qualify for long-term disability benefits.

According to the American Heart Association, approximately 2.2 million people in the United States are diagnosed with atrial fibrillation. This condition is caused by ineffective beating of the heart’s 2 small upper chambers. When the blood doesn’t pump correctly, pooling and clotting can occur. The blood clot could then move from the heart into an artery of the brain, which could result in a stroke.

The Federal Drug Administration (FDA) has just approved a new drug for patients with atrial fibrillation. Pradaxa, available in capsules, helps to prevent blood clots and stroke.

Like other anti-clotting drugs, the most common adverse reactions to patients taking Pradaxa were life-threatening, or fatal, bleeding.

Other symptoms from taking Pradaxa included:

  • dyspepsia (discomfort in stomach);
  • stomach pain;
  • heartburn;
  • nausea; and
  • bloating.

A medication guide, indicating the risk of serious bleeding, will be provided to patients each time they fill a prescription.

Individuals with atrial fibrillation are at a high risk of suffering a disabling stroke. If you have been disabled because of a stroke or other severe condition, contact a long-term disability representative, who can guide you through the application process for long-term disability benefits.

The long-term disability representatives at Disability Help Group have experience with cross examining medical and vocational experts and take time when speaking with you about your case. Call us today at 1-(800)-800-3332 for a FREE consultation.